Vanda Pharmaceuticals
VNDA
#8547
Rank
ยฃ0.20 B
Marketcap
ยฃ3.45
Share price
0.88%
Change (1 day)
-13.27%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2026 (TTM): -ยฃ0.14 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are ยฃ0.21 Billion. In 2025 the company made an earning of -ยฃ0.12 Billion a decrease over its 2024 earnings that were of -ยฃ30.73 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ0.14 Billion21.96%
2025 -ยฃ0.12 Billion271.79%
2024 -ยฃ30.73 Million191.43%
2023 -ยฃ10.55 Million-320.45%
2022 ยฃ4.78 M-84.99%
2021 ยฃ31.86 M54.8%
2020 ยฃ20.58 M19.42%
2019 ยฃ17.23 M4.93%
2018 ยฃ16.42 M-228.6%
2017 -ยฃ12.78 Million-8.98%
2016 -ยฃ14.04 Million-53.79%
2015 -ยฃ30.37 Million-30.18%
2014 -ยฃ43.5 Million173.08%
2013 -ยฃ15.93 Million-25.33%
2012 -ยฃ21.33 Million163.61%
2011 -ยฃ8.1 Million-221.15%
2010 ยฃ6.67 M-124.53%
2009 -ยฃ27.23 Million-29.44%
2008 -ยฃ38.59 Million-36.2%
2007 -ยฃ60.49 Million21.81%
2006 -ยฃ49.66 Million170.55%
2005 -ยฃ18.36 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.80 B-14,215.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ11.72 B-8,459.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
ยฃ5.21 B-3,820.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ25.38 B-18,194.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ5.81 B-4,241.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ8.99 B-6,514.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-ยฃ2.12 Million-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA